Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic Malignancies
Clinical trial NCT01179399 · TERMINATED
Trial details
- NCT number
- NCT01179399
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-10-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.